Association between HbA1c and the development of cystic fibrosis‐related diabetes

To examine HbA1c as a predictor of risk for future development of cystic fibrosis‐related diabetes and to assess the association with the development of retinopathy in people with cystic fibrosis‐related diabetes.

[1]  R. Holt,et al.  Unique challenges of cystic fibrosis‐related diabetes , 2018, Diabetic medicine : a journal of the British Diabetic Association.

[2]  W. Banya,et al.  HbA1c as a screening tool for cystic fibrosis related diabetes. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[3]  R. Rabasa-Lhoret,et al.  Glycated hemoglobin cannot yet be proposed as a screening tool for cystic fibrosis related diabetes. , 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[4]  A. Webb,et al.  Diabetic retinopathy in patients who do not meet the diagnostic criteria for cystic fibrosis related diabetes , 2015 .

[5]  L. George,et al.  Retinal screening of patients with cystic fibrosis-related diabetes in Wales -- a real eye opener. , 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[6]  D. Altman,et al.  Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD Statement , 2015, Diabetic medicine : a journal of the British Diabetic Association.

[7]  L. Kessler,et al.  Early assessment of glucose abnormalities during continuous glucose monitoring associated with lung function impairment in cystic fibrosis patients. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[8]  P. Royle,et al.  Screening for cystic fibrosis-related diabetes: a systematic review. , 2012, Health technology assessment.

[9]  J. Houghton,et al.  Management of distressing procedures in children and young people: time to adhere to the guidelines , 2011, Archives of Disease in Childhood.

[10]  J. Morton,et al.  Once daily insulin detemir in cystic fibrosis with insulin deficiency , 2011, Archives of Disease in Childhood.

[11]  B. Stanton,et al.  Iron and CF‐related anemia: Expanding clinical and biochemical relationships , 2011, Pediatric pulmonology.

[12]  P. Pencharz,et al.  Natural history of glucose intolerance in patients with cystic fibrosis: ten-year prospective observation program. , 2010, The Journal of pediatrics.

[13]  J. Morton,et al.  Early Glucose Abnormalities in Cystic Fibrosis Are Preceded by Poor Weight Gain , 2009, Diabetes Care.

[14]  J. Pilewski,et al.  Insulin Therapy to Improve BMI in Cystic Fibrosis–Related Diabetes Without Fasting Hyperglycemia , 2009, Diabetes Care.

[15]  Wiley Interscience,et al.  Predictors of mortality in adults with cystic fibrosis , 2007, Pediatric pulmonology.

[16]  D. Geddes,et al.  Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. , 2006, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[17]  S. Bell,et al.  Microvascular complications in cystic fibrosis-related diabetes mellitus: a case report. , 2000, JOP : Journal of the pancreas.

[18]  W. Warwick,et al.  Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. , 2000, American journal of respiratory and critical care medicine.

[19]  R. Holl,et al.  HbA1c is not recommended as a screening test for diabetes in cystic fibrosis. , 2000, Diabetes care.